4//SEC Filing
Wolfe Chris 4
Accession 0000899243-21-032272
CIK 0001863294other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 8:44 PM ET
Size
6.7 KB
Accession
0000899243-21-032272
Insider Transaction Report
Form 4
Wolfe Chris
Chief Financial Officer
Transactions
- Disposition to Issuer
Class B Common Stock, par value $0.0001 per share
2021-08-05−18,750→ 125,000 total→ Class A Common Stock (18,750 underlying)
Footnotes (2)
- [F1]The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Shares" in the Issuer's Registration Statement on Form S-1 (File No. 333-257679) (the "Registration Statement") and have no expiration date.
- [F2]On August 5, 2021, the Reporting Person forfeited 18,750 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Person's control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the "IPO") disclosing all material information about the Issuer and the IPO.
Documents
Issuer
DA32 Life Science Tech Acquisition Corp.
CIK 0001863294
Entity typeother
Related Parties
1- filerCIK 0001472624
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 8:44 PM ET
- Size
- 6.7 KB